Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Biallelic Variants in the Ectonucleotidase Entpd1 Cause a Complex Neurodevelopmental Disorder With Intellectual Disability, Distinct White Matter Abnormalities, and Spastic Paraplegia Publisher Pubmed



Calame DG1, 2, 3 ; Herman I1, 2, 3, 48 ; Maroofian R4 ; Marshall AE5 ; Donis KC6, 7 ; Fatih JM2 ; Mitani T2 ; Du H2 ; Grochowski CM2 ; Sousa SB8, 9 ; Gijavanekar C2 ; Bakhtiari S10, 11 ; Ito YA5 ; Rocca C4 Show All Authors
Authors
  1. Calame DG1, 2, 3
  2. Herman I1, 2, 3, 48
  3. Maroofian R4
  4. Marshall AE5
  5. Donis KC6, 7
  6. Fatih JM2
  7. Mitani T2
  8. Du H2
  9. Grochowski CM2
  10. Sousa SB8, 9
  11. Gijavanekar C2
  12. Bakhtiari S10, 11
  13. Ito YA5
  14. Rocca C4
  15. Hunter JV12
  16. Sutton VR2, 3
  17. Emrick LT1, 2, 3
  18. Boycott KM5
  19. Lossos A13
  20. Fellig Y14
  21. Prus E15
  22. Kalish Y15
  23. Meiner V16
  24. Suerink M17
  25. Ruivenkamp C17
  26. Muirhead K18
  27. Saadi NW19
  28. Zaki MS20
  29. Bouman A21
  30. Barakat TS21
  31. Skidmore DL22
  32. Osmond M5
  33. Silva TO7, 23
  34. Murphy D24
  35. Karimiani EG25
  36. Jamshidi Y25
  37. Jaddoa AG26
  38. Tajsharghi H27
  39. Jin SC28
  40. Abbaszadegan MR29, 30
  41. Ebrahimzadehvesal R30
  42. Hosseini S30
  43. Alavi S31
  44. Bahreini A32
  45. Zarean E33
  46. Salehi MM34
  47. Alsannaa NA35
  48. Zifarelli G36
  49. Bauer P36
  50. Robson SC37
  51. Cobanakdemir Z2, 38
  52. Travaglini L39, 40
  53. Nicita F39, 40
  54. Jhangiani SN41
  55. Gibbs RA41
  56. Posey JE2
  57. Kruer MC10, 11
  58. Kernohan KD5, 42
  59. Morales Saute JA7, 43, 44
  60. Houlden H4
  61. Vanderver A18, 45
  62. Elsea SH2
  63. Pehlivan D1, 2, 3
  64. Marafi D2, 46
  65. Lupski JR2, 3, 41, 47
Show Affiliations
Authors Affiliations
  1. 1. Section of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States
  2. 2. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States
  3. 3. Texas Children's Hospital, Houston, TX, United States
  4. 4. Department of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, United Kingdom
  5. 5. Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada
  6. 6. Graduate Program in Genetics and Molecular Biology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
  7. 7. Medical Genetics Service, Porto Alegre Clinical Hospital, Porto Alegre, Brazil
  8. 8. University Clinic of Genetics, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal
  9. 9. Medical Genetics Unit, Hospital Pediatrico, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal
  10. 10. Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, United States
  11. 11. Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine–Phoenix, Phoenix, AZ, United States
  12. 12. Division of Neuroradiology, Edward B. Singleton Department of Radiology, Texas Children's Hospital, Houston, TX, United States
  13. 13. Department of Neurology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University, Jerusalem, Israel
  14. 14. Department of Pathology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University, Jerusalem, Israel
  15. 15. Hematology and Bone Marrow Transplantation Division, Hadassah Medical Center and Hebrew University, Jerusalem, Israel
  16. 16. Department of Genetics, Hadassah Medical Center and Hebrew University, Jerusalem, Israel
  17. 17. Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands
  18. 18. Division of Neurology, Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, PA, United States
  19. 19. College of Medicine/University of Baghdad, Unit of Pediatric Neurology, Children Welfare Teaching Hospital, Baghdad, Iraq
  20. 20. Clinical Genetics Department, Human Genetics and Genome Research Institute, Center of Excellence of Human Genetics, National Research Centre, Dokki, Cairo, Egypt
  21. 21. Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, Netherlands
  22. 22. Department of Pediatrics, Dalhousie University, Halifax, NS, Canada
  23. 23. Postgraduate Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
  24. 24. Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
  25. 25. Genetics Section, Molecular and Clinical Sciences Institute, St George's University of London, London, United Kingdom
  26. 26. Pediatric Neurology, Children Welfare Teaching Hospital, Baghdad, Iraq
  27. 27. School of Health Sciences, Division Biomedicine, University of Skovde, Skovde, Sweden
  28. 28. Department of Genetics, Washington University School of Medicine, St Louis, MO, United States
  29. 29. Medical Genetics Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran
  30. 30. Pardis Pathobiology and Genetics Laboratory, Mashhad, Iran
  31. 31. Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran
  32. 32. Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States
  33. 33. Department of Perinatology, Isfahan University of Medical Sciences, Isfahan, Iran
  34. 34. Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran
  35. 35. Pediatric Services, John Hopkins Aramco Health Care, Dhahran, Saudi Arabia
  36. 36. Centogene GmbH, Rostock, Germany
  37. 37. Center for Inflammation Research, Transplantation, Departments of Medicine and Anesthesia, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States
  38. 38. Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, United States
  39. 39. Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesu Children's Hospital, Scientific Institute for Research and Health Care, Rome, Italy
  40. 40. Laboratory of Molecular Medicine, Department of Neuroscience, Bambino Gesu Children's Hospital, Scientific Institute for Research and Health Care, Rome, Italy
  41. 41. Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, United States
  42. 42. Newborn Screening Ontario, Ottawa, ON, Canada
  43. 43. Department of Internal Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
  44. 44. Neurology Service, Porto Alegre Clinical Hospital, Porto Alegre, Brazil
  45. 45. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
  46. 46. Department of Pediatrics, Faculty of Medicine, Kuwait University, Safat, Kuwait
  47. 47. Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States
  48. 48. Current address for Dr Herman: Boys Town Hospital Rd, Omaha, 69116, NE, United States

Source: Annals of Neurology Published:2022


Abstract

Objective: Human genomics established that pathogenic variation in diverse genes can underlie a single disorder. For example, hereditary spastic paraplegia is associated with >80 genes, with frequently only few affected individuals described for each gene. Herein, we characterize a large cohort of individuals with biallelic variation in ENTPD1, a gene previously linked to spastic paraplegia 64 (Mendelian Inheritance in Man # 615683). Methods: Individuals with biallelic ENTPD1 variants were recruited worldwide. Deep phenotyping and molecular characterization were performed. Results: A total of 27 individuals from 17 unrelated families were studied; additional phenotypic information was collected from published cases. Twelve novel pathogenic ENTPD1 variants are described (NM 001776.6): c.398_399delinsAA; p.(Gly133Glu), c.540del; p.(Thr181Leufs*18), c.640del; p.(Gly216Glufs*75), c.185 T > G; p.(Leu62*), c.1531 T > C; p.(*511Glnext*100), c.967C > T; p.(Gln323*), c.414-2_414-1del, and c.146 A > G; p.(Tyr49Cys) including 4 recurrent variants c.1109 T > A; p.(Leu370*), c.574-6_574-3del, c.770_771del; p.(Gly257Glufs*18), and c.1041del; p.(Ile348Phefs*19). Shared disease traits include childhood onset, progressive spastic paraplegia, intellectual disability (ID), dysarthria, and white matter abnormalities. In vitro assays demonstrate that ENTPD1 expression and function are impaired and that c.574-6_574-3del causes exon skipping. Global metabolomics demonstrate ENTPD1 deficiency leads to impaired nucleotide, lipid, and energy metabolism. Interpretation: The ENTPD1 locus trait consists of childhood disease onset, ID, progressive spastic paraparesis, dysarthria, dysmorphisms, and white matter abnormalities, with some individuals showing neurocognitive regression. Investigation of an allelic series of ENTPD1 (1) expands previously described features of ENTPD1-related neurological disease, (2) highlights the importance of genotype-driven deep phenotyping, (3) documents the need for global collaborative efforts to characterize rare autosomal recessive disease traits, and (4) provides insights into disease trait neurobiology. ANN NEUROL 2022;92:304–321. © 2022 American Neurological Association.
Experts (# of related papers)